U.S. Stem Cell, Inc.
USRM
$0.00
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -566.60K | -565.40K | -570.10K | -1.16M | -641.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 469.90K | 437.60K | 429.10K | 931.20K | 396.40K |
| Change in Net Operating Assets | 53.60K | 63.10K | 7.70K | 160.80K | 27.90K |
| Cash from Operations | -43.10K | -64.70K | -133.30K | -63.80K | -216.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 19.50K | 36.00K | 120.70K | 37.00K | 17.00K |
| Total Debt Repaid | -1.50K | -1.50K | -1.50K | -23.10K | -16.20K |
| Issuance of Common Stock | 0.00 | 50.00K | 10.00K | 25.00K | 225.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.00K | 84.50K | 129.20K | 38.90K | 225.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.00K | 19.80K | -4.10K | -24.90K | 9.10K |